1. The stability of extemporaneous paediatric formulations of propranolol hydrochloride;Ahmed;Aust. J. Hosp. Pharm.,1988
2. Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids;Allen;Am. J. Health-Syst. Pharm.,1996
3. Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids;Allen;Am. J. Health-Syst. Pharm,1998
4. The stability of an enalapril maleate oral solution prepared from tablets;Boulton;Aust. J. Hosp. Pharm.,1994
5. CDER, 2000. (U.S. Department of Health and Human Services Food and Drug Administration, Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER), 2000. Guidance for Industry: E11 Clinical Investigation of Medicinal Products in the Pediatric Population), Rockville, MD.